Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan
Authors:
- 9 January 2013
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 41 (3) , 218-223
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Mycobacterium abscessus: a new antibiotic nightmareJournal of Antimicrobial Chemotherapy, 2012
- Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary DiseaseClinical Infectious Diseases, 2011
- Mycobacterium abscessus: a new player in the mycobacterial fieldTrends in Microbiology, 2010
- Increasing Incidence of Nontuberculous Mycobacteria, Taiwan, 2000–2008Emerging Infectious Diseases, 2010
- Antibiotic Treatment of Mycobacterium abscessus Lung Disease: A Retrospective Analysis of 65 PatientsAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Clinical Management of Rapidly Growing Mycobacterial Cutaneous Infections in Patients after MesotherapyClinical Infectious Diseases, 2009
- Detection of lfrA and tap efflux pump genes among clinical isolates of non-pigmented rapidly growing mycobacteriaInternational Journal of Antimicrobial Agents, 2009
- An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Diagnosis and Treatment of Nontuberculous Mycobacterial Pulmonary Diseases: A Korean PerspectiveJournal of Korean Medical Science, 2005
- Comparison of the In Vitro Activity of the Glycylcycline Tigecycline (Formerly GAR-936) with Those of Tetracycline, Minocycline, and Doxycycline against Isolates of Nontuberculous MycobacteriaAntimicrobial Agents and Chemotherapy, 2002